| Head Ethics, Risk & Compliance (ERC) Advisory, Policies & Learning (m/w/d) |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Ethics Risk & Compliance |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 23, 2025 |
| IP Specialist |
Hyderabad (Office) |
India |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 23, 2025 |
| Country Ethics Risk and Compliance Head |
New Cairo |
Egypt |
International |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
9月 22, 2025 |
| Senior Legal Counsel DD & IT |
Barcelona Gran Vía |
Spain |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 19, 2025 |
| Senior Legal Counsel, Divestments |
East Hanover |
USA |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 18, 2025 |
| Legal Brand Protection Paralegal |
Basel (City) |
Switzerland |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 10, 2025 |
| Specialist, Customer Engagement Compliance |
Hyderabad (Office) |
India |
US |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 09, 2025 |
| Global Head IP Transactions |
Basel (City) |
Switzerland |
Legal |
Corporate |
Legal & Intellectual Property & Compl. |
9月 09, 2025 |
| Patent Attorney II, Biologics |
Cambridge (USA) |
USA |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 02, 2025 |
| Senior Legal Counsel - BD&L |
East Hanover |
USA |
Legal |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
9月 02, 2025 |
| ERC Manager, COE |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
9月 02, 2025 |
| Associate Director Ethics, Risk & Compliance (ERC) Oncology (m/w/d) |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Ethics Risk & Compliance |
Universal Hierarchy Node |
Legal & Intellectual Property & Compl. |
8月 19, 2025 |
| Legal Counsel |
Taipei |
Taiwan |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
7月 27, 2025 |